• Patient
    • Personalizing HPV+ Cancer Care
    • What is blood TTMV?
    • Tracking Your TTMV Score
    • Payment Portal & Support Resources
    • FAQs
  • Provider
    • Performance Metrics
    • Optimize OPSCC Surveillance
    • NavDx in HPV+ Cancer
    • What is Blood TTMV?
    • Testing with NavDx
    • Provider Resources
  • Use in HPV+ Cancers
  • Resources
    • Patient Resource
    • Physician Resources
    • Insurance and Billing
  • FAQs
    • Patient FAQs
    • Physician FAQs
    • Billing FAQs
  • STAY INFORMED
  • ORDER NAVDX

NavDx
Case Studies

TTMV-HPV DNA Detects
Recurrence Early

Case Study

NavDx Enables Early
Intervention of Persistent Disease

Case Study

TTMV-HPV DNA Monitoring Detects
Asymptomatic Disease Recurrence

Case Study
  • Privacy Policy
  • Terms of Use and Legal Information
  • Notice of Privacy Practices Under HIPPA

21 Hickory Drive, Suite 600, Waltham, MA 02451

  • www.naveris.com
  • contact@naveris.com

© Naveris Inc. US Patent 11,168,373

Sign up for more information

about how the NavDx test is helping
optimize HPV-driven cancer care

Interest (Required)
This field is for validation purposes and should be left unchanged.

This site is protected by reCAPTCHA and the Google Privacy Policy.
Terms of Service apply.

Manage Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Not consenting or withdrawing consent may adversely affect certain features and functions.

Cookie Settings Privacy Policy